Here's how I see it. First, the facts - CLX Health, LLC (CLX) is a JV between UST Global and SiriusIQ; and we have a Letter of Intent by and between PASO (Patient Access Solutions, Inc.) and CLX for the reverse merger, whereby CLX will acquire control of the company. (that is a period. those are the facts)
Further facts mixed with my interpretation and related suggestion(s):
The general terms sufficient for an LOI have been laid out, including CLX acquiring the 10M Preferred shares for control of the company. Further details TO BE DETERMINED and inked in the Definitive Agreement... COULD include negotiation between CLX and PASO on the VALUE of CLX being transferred to PASO in return for the 10M preferred shares and other possible yet-undetermined "consideration," among other merger specifics that are customarily negotiated and memorialized in a Definitive Agreement. This other possible "consideration" could be a block of Series C Preferred shares that might be agreed and allocated for distribution to significant partners. ...for example.
But there are many things such as this that COULD be worked into the deal, and many of the things that COULD be... will NOT be in the deal - simply because there are innumerable possibilities. We will learn what they've agreed, when it is announced and disclosed.
So to answer your question more directly, I believe - as others here have also suggested in prior posts - that the basic deal is between PASO and CLX, and that will not change. But the VALUE of the deal and the resulting entity (that is CLX) is about the only "tangible" information we have to work with, as we learn who are the partners... and how they describe these partners. I mean, we might get an idea of how siginificant or substantial they are in regards to the complete product/service solutions we bring to the market... and therefore just how f'ing big this thing could be.
